INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE

被引：0
|
作者：
Ohba, S. [1 ]
Hirose, Y. [1 ]
机构：
[1] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.45
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [21] Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells
    Lena, Annalisa
    Rechichi, Mariarosa
    Salvetti, Alessandra
    Bartoli, Barbara
    Vecchio, Donatella
    Scarcelli, Vittoria
    Amoroso, Rosina
    Benvenuti, Lucia
    Gagliardi, Rolando
    Gremigni, Vittorio
    Rossi, Leonardo
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [22] MicroRNA-21 Inhibition Enhances In Vitro Chemosensitivity of Temozolomide-resistant Glioblastoma Cells
    Wong, Stanley Thian Sze
    Zhang, Xiao-Qin
    Zhuang, James Tin-Fong
    Chan, Hin-Lun
    Li, Chi-Han
    Leung, Gilberto Ka Kit
    ANTICANCER RESEARCH, 2012, 32 (07) : 2835 - 2841
  • [23] Erratum: Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
    C R R Rocha
    C C M Garcia
    D B Vieira
    A Quinet
    L C de Andrade-Lima
    V Munford
    J E Belizário
    C F M Menck
    Cell Death & Disease, 2015, 6 : e1727 - e1727
  • [24] Temozolomide-resistant MGMT/MSI double-negative cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival
    El Touny, Lara H.
    Harris, Erik
    Hose, Curtis
    Connelly, John
    Monks, Anne
    Newton, Dianne
    Stockwin, Luke
    Hollingshead, Melinda
    Parchment, Ralph
    Doroshow, James H.
    Teicher, Beverly A.
    Rapisarda, Annamaria
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [25] Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Friedman, Allan H.
    Bigner, Darell D.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Walker, Amy
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1262 - 1267
  • [26] Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas
    Cho, Hee-Yeon
    Wang, Weijun
    Jhaveri, Niyati
    Torres, Shering
    Tseng, Joshua
    Leong, Michelle N.
    Lee, David Jungpa
    Goldkorn, Amir
    Xu, Tong
    Petasis, Nicos A.
    Louie, Stan G.
    Schoenthal, Axel H.
    Hofman, Florence M.
    Chen, Thomas C.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2462 - 2472
  • [27] DEVELOPMENT OF ANTITUMOR COMPOUNDS FOR TEMOZOLOMIDE-RESISTANT TUMORS
    Lee, Sang Y.
    Slagle-Webb, Becky
    Rizk, Elias
    Miller, Patti
    Zhang, Xuesheng
    Ponnuru, Padma
    Sheehan, Jonas
    Connor, James R.
    NEURO-ONCOLOGY, 2009, 11 (05) : 595 - 595
  • [28] Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition
    Wang, Jianjiao
    Zhou, Fenggang
    Li, Yang
    Li, Qingsong
    Wu, Zhichao
    Yu, Lili
    Yuan, Fei
    Liu, Jie
    Tian, Yu
    Cao, Yu
    Zhao, Yan
    Zheng, Yongri
    CELL CYCLE, 2017, 16 (24) : 2355 - 2365
  • [29] Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas
    He, Weiliang
    Liu, Ran
    Yang, Shao-Hua
    Yuan, Fang
    ANTI-CANCER DRUGS, 2015, 26 (03) : 293 - 300
  • [30] Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas
    Triebels, VHJM
    Taphoorn, MJB
    Brandes, AA
    Menten, J
    Frenay, M
    Tosoni, A
    Kros, JM
    Biemond-ter Stege, E
    Enting, RH
    Allgeier, A
    van Heuvel, I
    van den Bent, MJ
    NEUROLOGY, 2004, 63 (05) : 904 - 906
12345